287 related articles for article (PubMed ID: 34019660)
1. Rare Variants in Triglycerides-Related Genes Increase Pancreatitis Risk in Multifactorial Chylomicronemia Syndrome.
Paquette M; Amyot J; Fantino M; Baass A; Bernard S
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3473-e3482. PubMed ID: 34019660
[TBL] [Abstract][Full Text] [Related]
2. Acute pancreatitis risk in multifactorial chylomicronemia syndrome depends on the molecular cause of severe hypertriglyceridemia.
Guay SP; Paquette M; Taschereau A; Girard L; Desgagné V; Bouchard L; Bernard S; Baass A
Atherosclerosis; 2024 May; 392():117489. PubMed ID: 38448342
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of Mutations and Long-Term Clinical Outcomes in Genetic Chylomicronemia Syndromes.
D'Erasmo L; Di Costanzo A; Cassandra F; Minicocci I; Polito L; Montali A; Ceci F; Arca M
Arterioscler Thromb Vasc Biol; 2019 Dec; 39(12):2531-2541. PubMed ID: 31619059
[TBL] [Abstract][Full Text] [Related]
4. Pancreatitis polygenic risk score is associated with acute pancreatitis in multifactorial chylomicronemia syndrome.
Guay SP; Paquette M; Taschereau A; Desgagné V; Bouchard L; Bernard S; Baass A
J Clin Lipidol; 2024; 18(3):e413-e422. PubMed ID: 38443284
[TBL] [Abstract][Full Text] [Related]
5. Analyses of familial chylomicronemia syndrome in Pereira, Colombia 2010-2020: a cross-sectional study.
Rodriguez FH; Estrada JM; Quintero HMA; Nogueira JP; Porras-Hurtado GL
Lipids Health Dis; 2023 Mar; 22(1):43. PubMed ID: 36978188
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biochemical features of different molecular etiologies of familial chylomicronemia.
Hegele RA; Berberich AJ; Ban MR; Wang J; Digenio A; Alexander VJ; D'Erasmo L; Arca M; Jones A; Bruckert E; Stroes ES; Bergeron J; Civeira F; Witztum JL; Gaudet D
J Clin Lipidol; 2018; 12(4):920-927.e4. PubMed ID: 29748148
[TBL] [Abstract][Full Text] [Related]
7. Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride.
Buonuomo PS; Rabacchi C; Macchiaiolo M; Trenti C; Fasano T; Tarugi P; Bartuli A; Bertolini S; Calandra S
J Clin Lipidol; 2017; 11(6):1329-1337.e3. PubMed ID: 28951076
[TBL] [Abstract][Full Text] [Related]
8. Familial chylomicronemia syndrome: an under-recognized cause of severe hypertriglyceridaemia.
Baass A; Paquette M; Bernard S; Hegele RA
J Intern Med; 2020 Apr; 287(4):340-348. PubMed ID: 31840878
[TBL] [Abstract][Full Text] [Related]
9. [Familial chylomicronemia syndrome: pediatric experience in Argentina].
Araujo MB; Eiberman G; Etcheverry N; Pacheco G
Arch Argent Pediatr; 2022 Jun; 120(3):e123-e127. PubMed ID: 35533124
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Compound Heterozygous LMF1 Variants in a Patient with Severe Hypertriglyceridemia - Case Report and Literature Review.
Cao C; Liu Y; Liu L; Wang X
J Atheroscler Thromb; 2024 Jul; 31(7):1106-1111. PubMed ID: 38462482
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia.
Caddeo A; Mancina RM; Pirazzi C; Russo C; Sasidharan K; Sandstedt J; Maurotti S; Montalcini T; Pujia A; Leren TP; Romeo S; Pingitore P
Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):158-164. PubMed ID: 29288010
[TBL] [Abstract][Full Text] [Related]
12. Chylomicronemia: Differences between familial chylomicronemia syndrome and multifactorial chylomicronemia.
Paquette M; Bernard S; Hegele RA; Baass A
Atherosclerosis; 2019 Apr; 283():137-142. PubMed ID: 30655019
[TBL] [Abstract][Full Text] [Related]
13. Biochemical, Clinical, and Genetic Characteristics of Mexican Patients with Primary Hypertriglyceridemia, Including the First Case of Hyperchylomicronemia Syndrome Due to GPIHBP1 Deficiency.
Rodríguez-Gutiérrez PG; Colima-Fausto AG; Zepeda-Olmos PM; Hernández-Flores TJ; González-García JR; Magaña-Torres MT
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613909
[TBL] [Abstract][Full Text] [Related]
14. Chylomicronemia syndrome: Familial or not?
Warden BA; Minnier J; Duell PB; Fazio S; Shapiro MD
J Clin Lipidol; 2020; 14(2):201-206. PubMed ID: 32107181
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society.
Ariza MJ; Rioja J; Ibarretxe D; Camacho A; Díaz-Díaz JL; Mangas A; Carbayo-Herencia JA; Ruiz-Ocaña P; Lamíquiz-Moneo I; Mosquera D; Sáenz P; Masana L; Muñiz-Grijalvo O; Pérez-Calahorra S; Valdivielso P;
J Clin Lipidol; 2018; 12(6):1482-1492.e3. PubMed ID: 30150141
[TBL] [Abstract][Full Text] [Related]
16. Role of lipoprotein lipase activity measurement in the diagnosis of familial chylomicronemia syndrome.
Rioja J; Ariza MJ; Benítez-Toledo MJ; Espíldora-Hernández J; Coca-Prieto I; Arrobas-Velilla T; Camacho A; Olivecrona G; Sánchez-Chaparro MÁ; Valdivielso P
J Clin Lipidol; 2023; 17(2):272-280. PubMed ID: 36813655
[TBL] [Abstract][Full Text] [Related]
17. Molecular and functional characterization of familial chylomicronemia syndrome.
Teramoto R; Tada H; Kawashiri MA; Nohara A; Nakahashi T; Konno T; Inazu A; Mabuchi H; Yamagishi M; Hayashi K
Atherosclerosis; 2018 Feb; 269():272-278. PubMed ID: 29153744
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the chylomicron-TG to VLDL-TG ratio for type I hyperlipoproteinemia diagnostic.
Rioja J; Ariza MJ; García-Casares N; Coca-Prieto I; Arrobas T; Muñiz-Grijalvo O; Mangas A; Ibarretxe D; Sánchez-Chaparro MÁ; Valdivielso P
Eur J Clin Invest; 2020 Dec; 50(12):e13345. PubMed ID: 32649781
[TBL] [Abstract][Full Text] [Related]
19. A Comprehensive Update on the Chylomicronemia Syndrome.
Goldberg RB; Chait A
Front Endocrinol (Lausanne); 2020; 11():593931. PubMed ID: 33193106
[TBL] [Abstract][Full Text] [Related]
20. Familial chylomicronemia syndrome: case reports of siblings with deletions of the GPIHBP1 gene.
Kim KY; Heo YJ; Ko JM; Lee YA; Shin CH; Ki CS; Lee YJ
BMC Endocr Disord; 2024 Apr; 24(1):47. PubMed ID: 38622573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
